Les tudes pharmacologiques indiquent que le tirzpatide a une affinit plus forte pour le rcepteur GIP que pour le GLP-1, avec une signalisation biaise au niveau du GLP-1
Reddy s Laboratories Ltd., Lupin Limited, Intas Pharmaceuticals Ltd., Alvotech, Bio-Thera Solutions Ltd., Organon & Co., Fresenius Kabi AG, Coherus BioSciences Inc., Dong-A ST Co., Ltd., Gan & Lee Pharmaceuticals, Hikma Pharmaceuticals PLC, Shanghai Henlius Biotech Inc., and Zhejiang Huahai Pharmaceutical Co., Ltd
For a deeper look at the mechanism, read how GLP-1 medications slow digestion
What distinguishes ipamorelin from every other growth hormone releasing peptide (GHRP) is its selectivity: it releases GH without stimulating cortisol, ACTH, or prolactin, even at doses more than 200 times the amount needed for maximal GH release